Loading...
Clinical use of amyloid-positron emission tomography neuroimaging: Practical and bioethical considerations
Until recently, estimation of β-amyloid plaque density as a key element for identifying Alzheimer's disease (AD) pathology as the cause of cognitive impairment was only possible at autopsy. Now with amyloid-positron emission tomography (amyloid-PET) neuroimaging, this AD hallmark can be detecte...
Na minha lista:
| Udgivet i: | Alzheimers Dement (Amst) |
|---|---|
| Main Authors: | , , , , , , , , , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Elsevier
2015
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4878065/ https://ncbi.nlm.nih.gov/pubmed/27239516 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.dadm.2015.06.006 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|